Oct 2026· American Journal of Human Genetics· 0 citations· 54 references
Medicine
TL;DR
Variant-level functional assays expand the phenotypic spectrum of IDUA-associated disease to include late-onset retinal-predominant or apparently isolated retinitis pigmentosa and indicate that residual enzyme activity likely contributes to systemic sparing, highlighting the value of integrated genomic, biochemical, and functional analyses to advance understanding in attenuated metabolic disease.
Abstract
Bi-allelic variants in IDUA classically cause mucopolysaccharidosis type I (MPS I), a multisystem lysosomal storage disorder. This study describes 14 individuals from 12 families presenting with retinitis pigmentosa, later attributed to bi-allelic IDUA genotypes. Notably, seven individuals, despite comprehensive systemic assessments, showed no features consistent with MPS I at last assessment (aged 46-73 years). Leukocyte α-L-iduronidase activity was reduced but not abolished across all individuals assessed (n = 9), supporting a shared mechanistic basis for the mild, retina-predominant, or exclusively retinal phenotype. No individual carried bi-allelic null genotypes; most had a loss-of-function allele paired with a missense variant, consistent with an overall hypomorphic genotype. Variant-level functional assays, using a cell-based expression platform assessing enzyme activity and protein abundance to derive relative specific activity (RSA), showed that several missense alleles confer very low residual activity and/or impaired abundance/processing, with RSA typically in the ∼0.5%-1.5% range. The recurrent missense c.298A>G (p.Arg100Gly) variant showed no protein or catalytic effect; targeted long-read transcript analysis instead demonstrated predominant loss-of-function mis-splicing with a small fraction of correctly spliced transcript (∼1%-2%), explaining residual activity in vivo. Together, these data expand the phenotypic spectrum of IDUA-associated disease to include late-onset retinal-predominant or apparently isolated retinitis pigmentosa and indicate that residual enzyme activity likely contributes to systemic sparing, highlighting the value of integrated genomic, biochemical, and functional analyses to advance understanding in attenuated metabolic disease.
Mucopolysaccharidosis Type I (MPS I) is a rare lysosomal storage disorder caused by α‐l‐iduronidase deficiency, leading to glycosaminoglycan accumulation and multisystem involvement. Wolf–Hirschhorn Syndrome (WHS) is a chromosomal disorder characterized by growth delay, dysmorphism, and developmental impairment. Becaus...
Karla Cifuentes-Uribe, Sandrine Girard, R. Froissart et al.· JIMD Reports· 0 citations
Genotype–phenotype analyses indicated that the presence of a truncating variant was associated with increased likelihood of skeletal involvement and reduced likelihood of hepatobiliary disease compared with individuals harbouring only missense variants, and variants located outside repeat protein domains were associate...
Zoe Webster, Lisa Woods, R. Dalziel et al.· Human Mutation· 0 citations
Bi-allelic MED16 variants underlie the recently described MEDopathy termed Guillouet-Gordon syndrome (GGNS, MIM #621220), characterized by neurodevelopmental and structural anomalies. To date, 27 individuals with GGNS have been reported, collectively harboring 28 distinct compound heterozygous or homozygous MED16 varia...
Sarah E. Seese, Linda M. Reis, Allison Genchanok et al.· American Journal of Medical...· 0 citations
BACKGROUND
PRPF31-associated inherited retinal dystrophy is an autosomal dominant form of retinitis pigmentosa (RP), typically caused by haploinsufficiency. Although affected individuals generally exhibit early-onset nyctalopia and progressive visual field loss, the clinical and genetic characteristics associated with...
Wakako Okayama-Miyazaki, Akiko Yoshida, Xiao-Xu Han et al.· Ophthalmic Genetics· 0 citations
W Whole-exome sequencing identified compound heterozygous NEU1 variants, including a previously reported pathogenic variant, c.679G > A (p.Gly227Arg), and a novel in-frame deletion, which is not represented in databases c.367_369del (p.Pro123del).
O. C. Mazur, S. Baiko, A. Mikhalenka et al.· SN Comprehensive Clinical Me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.